Puma Biotechnology Inc (PBYI NASDAQ) stock market data APIs
$4.333
0.17(3.9%)
as of September 17, 2025
Try our APIs with
free plan!
Puma Biotechnology Inc Financial Data Overview
Price chart is built with
Anychart
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Prev. Close
4.333
Open
4.5078
High
4.5677
Low
4.314
52 wk Range
2.32-6.07
Market Cap
219 M
P/E Ratio
4.3838
Shares Outstanding
50 371 K
Revenue
238 M
EPS
0.15
Beta
1.368
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Puma Biotechnology Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Puma Biotechnology Inc data using free add-ons & libraries
Get Puma Biotechnology Inc Fundamental Data
Puma Biotechnology Inc Fundamental data includes:
- Net Revenue: 238 M
- EBITDA: 57 342 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: 0.09
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Puma Biotechnology Inc News
New
3 Promising Penny Stocks With Market Caps Under $700M
As the Dow Jones Industrial Average gains traction while the Nasdaq and S&P 500 experience slight declines, investors are keenly watching for signals from the Federal Reserve's anticipated interest ra...
3 Penny Stocks With Market Caps Under $2B To Consider
As the U.S. stock market navigates a period of anticipation around potential interest rate cuts, with indices like the S&P 500 and Nasdaq recently hitting new highs before pulling back, investors are ...
3 Penny Stocks With Market Caps Over $30M To Consider
As the Nasdaq and S&P 500 reach record highs, investors are keenly watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. Penny stocks may be a throwbac...
Strata Critical Medical Leads Our Top 3 Penny Stock Picks
As the Nasdaq and S&P 500 reach record highs, investors are keenly watching the Federal Reserve's upcoming interest rate decision, which could influence market dynamics. Penny stocks, often associated...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
